Jamal El-Mosleh
Algemeen Directeur bij ELICERA THERAPEUTICS AB
Profiel
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB.
Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB.
He also served on the board at Elypta AB.
He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Actieve functies van Jamal El-Mosleh
Bedrijven | Functie | Begin |
---|---|---|
ELICERA THERAPEUTICS AB | Algemeen Directeur | 01-01-2020 |
Eerdere bekende functies van Jamal El-Mosleh
Bedrijven | Functie | Einde |
---|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Directeur/Bestuurslid | 01-01-2020 |
ANNEXIN PHARMACEUTICALS AB | Algemeen Directeur | 01-01-2019 |
MENDUS AB | Algemeen Directeur | 01-10-2016 |
Opleiding van Jamal El-Mosleh
Chalmers University of Technology | Graduate Degree |
Chalmers School of Entrepreneurship | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MENDUS AB | Health Technology |
ANNEXIN PHARMACEUTICALS AB | Health Technology |
ELICERA THERAPEUTICS AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Technology Services |